» Articles » PMID: 34021148

Peripheral and Lung Resident Memory T Cell Responses Against SARS-CoV-2

Abstract

Resident memory T cells (T) positioned within the respiratory tract are probably required to limit SARS-CoV-2 spread and COVID-19. Importantly, T are mostly non-recirculating, which reduces the window of opportunity to examine these cells in the blood as they move to the lung parenchyma. Here, we identify circulating virus-specific T cell responses during acute infection with functional, migratory and apoptotic patterns modulated by viral proteins and associated with clinical outcome. Disease severity is associated predominantly with IFNγ and IL-4 responses, increased responses against S peptides and apoptosis, whereas non-hospitalized patients have increased IL-12p70 levels, degranulation in response to N peptides and SARS-CoV-2-specific CCR7 T cells secreting IL-10. In convalescent patients, lung-T are frequently detected even 10 months after initial infection, in which contemporaneous blood does not reflect tissue-resident profiles. Our study highlights a balanced anti-inflammatory antiviral response associated with a better outcome and persisting T cells as important for future protection against SARS-CoV-2 infection.

Citing Articles

Tissue-Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy.

Xu L, Ye L, Huang Q MedComm (2020). 2025; 6(3):e70132.

PMID: 40066223 PMC: 11892159. DOI: 10.1002/mco2.70132.


Protective SARS-CoV-2-specific T cells take up residence.

Moss P Nat Immunol. 2025; 26(3):331-332.

PMID: 40021899 DOI: 10.1038/s41590-025-02095-w.


COVID-19 clinical presentation, management, and epidemiology: a concise compendium.

Maison D, Tasissa H, Deitchman A, Peluso M, Deng Y, Miller F Front Public Health. 2025; 13:1498445.

PMID: 39957982 PMC: 11826932. DOI: 10.3389/fpubh.2025.1498445.


A vaccine platform targeting lung-resident memory CD4 T-cells provides protection against heterosubtypic influenza infections in mice and ferrets.

Ko K, Bae H, Park J, Lee J, Park S, Heo J Nat Commun. 2024; 15(1):10368.

PMID: 39609429 PMC: 11604757. DOI: 10.1038/s41467-024-54620-4.


B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2.

Perdiguero B, Alvarez E, Marcos-Villar L, Sin L, Lopez-Bravo M, Valverde J Vaccines (Basel). 2024; 12(11).

PMID: 39591118 PMC: 11598604. DOI: 10.3390/vaccines12111213.


References
1.
Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

2.
Ejrnaes M, Filippi C, Martinic M, Ling E, Togher L, Crotty S . Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006; 203(11):2461-72. PMC: 2118120. DOI: 10.1084/jem.20061462. View

3.
Woodland D, Scott I . T cell memory in the lung airways. Proc Am Thorac Soc. 2005; 2(2):126-31. PMC: 2713315. DOI: 10.1513/pats.200501-003AW. View

4.
Vabret N, Britton G, Gruber C, Hegde S, Kim J, Kuksin M . Immunology of COVID-19: Current State of the Science. Immunity. 2020; 52(6):910-941. PMC: 7200337. DOI: 10.1016/j.immuni.2020.05.002. View

5.
Lakhani S, Flavell R . Caspases and T lymphocytes: a flip of the coin?. Immunol Rev. 2003; 193:22-30. DOI: 10.1034/j.1600-065x.2003.00046.x. View